Caitong International Asset Management Co., LTD Zai Lab LTD Transaction History

Caitong International Asset Management Co., LTD

  • $144 Billion
  • Q3 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
SELL
$24.32 - $43.03 $47,837 - $84,640
-1,967 Reduced 94.52%
114 $3.99 Million
Q1 2025

May 13, 2025
BUY
$24.29 - $38.35 $50,547 - $79,806
2,081 New
2,081 $75.2 Million

Others Institutions Holding ZLAB

# of Institutions
150
Shares Held
34.1M
Call Options Held
168K
Put Options Held
222K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.13B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Caitong International Asset Management Co., LTD Portfolio

Follow Caitong International Asset Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email